Effects of antiepileptic drugs on motor cortex excitability in humans: A transcranial magnetic stimulation study

Annals of Neurology

Volumn 40, Issue 3, 1996, Pages 367-378

  Ziemann, U ^a   Lonnecker S ^a   Steinhoff, B J ^a   Paulus, W ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; BACLOFEN; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; LOSIGAMONE; SODIUM CHANNEL BLOCKING AGENT; VIGABATRIN;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CARDIOTOXICITY; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; FATIGUE; GABAERGIC SYSTEM; GASTROINTESTINAL SYMPTOM; HUMAN; MOTOR CORTEX; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE POTENTIAL; NEUROTOXICITY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 0029787246     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400306     Document Type: Article

References (49)

1. Engel J Jr. Seizures and epilepsy. Philadelphia: Davis, 1989
2. Macdonald RL, Meldrum BS. Principles of antiepileptic drug action. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. New York: Raven, 1995:61-77
3. Swinyard EA. Electrically induced convulsions. In: Purpura DP, Penry JK, Tower DB, Walter RD, eds. Experimental models of epilepsy. New York: Raven, 1972:443-458
4. Woodbury DM. Applications to drug evaluations. In: Purpura DP, Penry JK, Tower DB, Walter RD, eds. Experimental models of epilepsy. New York: Raven, 1972:557-583
5. Wurpel JND. Baclofen prevents rapid amygdala kindling in adult rats. Experientia 1994;50:475-478
6. Ziemann U, Lönnecker S, Paulus W. Inhibition of human motor cortex by ethanol. A transcranial magnetic stimulation study. Brain 1995;118:1437-1446
7. Ziemann U, Lönnecker S, Steinhoff BJ, Paulus W. The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res 1996;109:127-135
8. Kujirai T, Caramia MD, Rothwell JC, et al. Corticocortical inhibition in human motor cortex. J Physiol (Lond) 1993;471: 501-519
9. Ziemann U, Rothwell JC, Ridding M. Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol (Lond) 1996 (in press)
10. Fuhr P, Agostino R, Hallett M. Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol 1991;81:257-262
11. Ziemann U, Netz J, Szelenyi A, Hömberg V. Spinal and supraspinal mechanisms contribute to the silent period in the contracting soleus muscle after transcranial magnetic stimulation of human motor cortex. Neurosci Lett 1993;156:167-171
12. Hallett M. Transcranial magnetic stimulation: negative effects. In: Fahn S, Hallett M, Lüders HO, Marsden CD, eds. Negative motor phenomena. Philadelphia: Lippincott-Raven, 1995: 107-114
13. Ben-Menachem E. Vigabatrin. Chemistry, absorption, distribution, and elimination. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. New York: Raven, 1995:915-923
14. Wilson SA, Lockwood RJ, Thickbroom GW, Mastaglia FL. The muscle silent period following transcranial magnetic cortical stimulation. J Neurol Sci 1993;114:216-222
15. Brasil-Neto JP, Cohen LG, Panizza M, et al. Optimal focal transcranial magnetic activation of the human motor cortex: effects of coil orientation, shape of the induced current pulse, and stimulus intensity. J Clin Neurophysiol 1992;9:132-136
16. Werhahn KJ, Fong JKY, Meyer B-U, et al. The effect of magnetic coil orientation on the latency of surface EMG and single motor unit responses in the first dorsal interosseous muscle. Electroencephalogr Clin Neurophysiol 1994;93:138-146
17. Rudiak D, Marg E. Finding the depth of magnetic brain stimulation: a re-evaluation. Electroencephalogr Clin Neurophysiol 1994;93:358-371
18. Mavroudakis N, Caroyer JM, Brunko E, Zegers de Beyl D. Effects of diphenylhydantoin on motor potentials evoked with magnetic stimulation. Electroencephalogr Clin Neurophysiol 1994;93:428-433
19. Roth SH. Physical mechanics of anesthesia. Annu Rev Pharmacol Toxicol 1979;19:159
20. Schmid UD, Boll J, Liechti S, et al. Influence of some anesthetic agents on muscle responses to transcranial magnetic cortex stimulation: a pilot study in humans. Neurosurgery 1992; 30:85-92
21. Schönle PW, Isenberg C, Crozier TA, et al. Changes of transcranially evoked motor responses in man by midazolam, a short acting benzodiazepine. Neurosci Lett 1989;101:321-324
22. Burke D, Hicks R, Gandevia SC, et al. Direct comparison of corticospinal volleys in human subjects to transcranial magnetic and electrical stimulation. J Physiol (Lond) 1993;470:383-393
23. Rothwell JC, Ridding M, Quartarone A, Amassian VE. Threshold conditioning stimuli can produce short latency facilitation of responses to transcranial magnetic stimulation of the human motor cortex. J Physiol (Lond) 1994;475:40P-41P
24. Datta AK, Harrison LM, Stephens JA. Task-dependent changes in the size of response to magnetic brain stimulation in human first dorsal interosseous muscle. J Physiol (Lond) 1989;418:13-23
25. Brouwer B, Ashby P, Midroni G. Excitability of corticospinal neurons during tonic muscle contractions in man. Exp Brain Res 1989;74:649-652
26. Edgley SA, Eyre JA, Lemon RN, Miller S. Direct and indirect activation of corticospinal neurones by electrical and magnetic stimulation in the anaesthetized macaque monkey. J Physiol (Lond) 1992;446:224P
27. Day BL, Dressler D, Maertens de Noordhout A, et al. Electric and magnetic stimulation of human motor cortex: surface EMG and single motor unit responses. J Physiol (Lond) 1989; 412:449-473
28. Taylor CP. Gabapentin. Mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. New York: Raven, 1995:829-841
29. Goldlust A, Su T-Z, Welty DF, et al. Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA. Epilepsy Res 1995;22:1-12
30. Krnjevic K, Randic M, Straughan DW. Cortical inhibition. Nature 1964;201:1294-1296
31. Krnjevic K, Randic M, Straughan DW. Pharmacology of cortical inhibition. J Physiol 1966;184:78-105
32. Priori A, Beradelli A, Inghilleri M, et al. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain 1994;117:317-323
33. Cantello R, Gianelli M, Bettucci D, et al. Parkinson's disease rigidity: magnetic motor evoked potentials in a small hand muscle. Neurology 1991;41:1449-1456
34. Valls-Solé J, Pascual-Leone A, Brasil-Neto JP, et al. Abnormal facilitation of the response to transcranial magnetic stimulation in patients with Parkinson's disease. Neurology 1994;44:735-741
35. Ridding MC, Inzelberg R, Rothwell JC. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol 1995;37:181-188
36. Ribak CE. Contemporary methods in neurocytology and their application to the study of epilepsy. In: Delgado-Escueta AV, Ward AA JR, Woodbury DM, Porter RJ, eds. Basic mechanisms of the epilepsies. Molecular and cellular approaches. New York: Raven, 1986:739-764
37. Schwartzkroin PA. Cellular electrophysiology of human epilepsy. Epilepsy Res 1994;17:185-192
38. Avoli M, Oliver A. Electrophysiological properties and synaptic responses in the deep layers of the human epileptogenic neocortex in vitro. J Neurophysiol 1989;61:589-606
39. Reutens DC, Berkovic SF. Increased cortical excitability in generalised epilepsy demonstrated with transcranial magnetic stimulation. Lancet 1992;339:362-363
40. Reutens DC, Puce A, Berkovic SF. Cortical hyperexcitability in progressive myoclonus epilepsy: a study with transcranial magnetic stimulation. Ann Neurol 1993;43:186-192
41. Fong JKY, Werhahn KJ, Rothwell JC, et al. Motor cortex excitability in focal and generalized epilepsy. J Physiol (Lond) 1993;459:468P
42. Brown P, Ridding MC, Werhahn KJ, et al. Abnormalities of the balance between inhibition and excitation in the motor cortex of patients with cortical myoclonus. Brain 1996;119: 309-317
43. Caramia MD, Gigli G, Iani C, et al. Distinguishing forms of generalized epilepsy using magnetic brain stimulation. Electroencephalogr Clin Neurophysiol 1996;98:14-19
44. Jung MJ, Palfreyman MG. Vigabatrin. Mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. New York: Raven, 1995:903-913
45. Petroff OAC, Rothman DL, Behar KL, et al. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol 1996;39:95-99
46. Bowery NG, Hill DR, Hudson AL, et al. (-)Baclofen decreases neurotransmitter release in the mammalian CNS by action at a novel GABA receptor. Nature 1980;283:92-94
47. Macdonald RL. Carbamazepine. Mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. New York: Raven, 1995:491-498
48. Leach MJ, Lees G, Riddall DR. Lamotrigine. Mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. New York: Raven, 1995:861-869
49. Köhr G, Heinemann U. Effects of the tetronic acid derivatives AO33 (losigamone) and AO78 on epileptiform activity and on stimulus-induced calcium concentration changes in rat hippocampal slices. Epilepsy Res 1990;7:49-58